Literature DB >> 6487454

Measurement of specific [3H]-ouabain binding to different types of human leucocytes.

N A Boon, V M Oh, E A Taylor, T Johansen, J K Aronson, D G Grahame-Smith.   

Abstract

We have studied the specific binding of [3H]-ouabain to intact mononuclear leucocytes (82% lymphocytes) and polymorphonuclear leucocytes. In both types of cells [3H]-ouabain binding was saturable, confined to a single site of high affinity, slow to reach equilibrium, slow to reverse, temperature-dependent, competitively antagonized by potassium, and facilitated by the presence of divalent cations. The equilibrium dissociation constants were 2.4 +/- 0.7 nmol/l (polymorphs) and 2.4 +/- 0.4 nmol/l (mononuclear cells) (NS). The values of maximal specific ouabain binding, measured by Scatchard analysis of concentration vs binding curves (Bmax), were 33.9 +/- 6.0 fmol/10(6) cells (polymorphs) and 59.3 +/- 11.6 fmol/10(6) cells (mononuclear cells) (P less than 0.02). The corresponding numbers of sites per cell were 20415 +/- 3616 and 35712 +/- 6986 respectively (P less than 0.02). When the numbers of binding sites were expressed per square micron of cell surface area the difference between the two cell types was proportionately greater (83 and 186 sites per micron 2 respectively). We conclude that the [3H]-ouabain binding sites on mononuclear and polymorphonuclear leucocytes are similar in nature, but different in both number and density on the cell surface. Measurements of Bmax in mixed cell populations should therefore take account of cell type as well as cell size and number.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487454      PMCID: PMC1463515          DOI: 10.1111/j.1365-2125.1984.tb02447.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Leucocyte sodium transport in uraemia.

Authors:  R P Edmondson; P J Hilton; N F Jones; J Patrick; R D Thomas
Journal:  Clin Sci Mol Med       Date:  1975-09

2.  The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects.

Authors:  A Schwartz; G E Lindenmayer; J C Allen
Journal:  Pharmacol Rev       Date:  1975-03       Impact factor: 25.468

3.  Ouabain binding to intact lymphocytes. Enhancement by phytohemagglutinin and leucoagglutinin.

Authors:  M R Quastel; J G Kaplan
Journal:  Exp Cell Res       Date:  1975-09       Impact factor: 3.905

4.  Kinetics of the glucocorticoid hormone-receptor interaction. False association constants determined in slowly equilibrating systems.

Authors:  P Arányi
Journal:  Biochim Biophys Acta       Date:  1979-05-16

5.  Ouabain-receptor interactions in (Na + +K + )-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants.

Authors:  E Erdmann; W Schoner
Journal:  Biochim Biophys Acta       Date:  1973-05-11

6.  Binding of the cardiac glycoside ouabain to intact cells.

Authors:  P F Baker; J S Willis
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

7.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.

Authors:  J K Aronson; D G Grahame-Smith; K F Hallis; A Hibble; F Wigley
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

10.  Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes.

Authors:  E Erdmann; W Hasse
Journal:  J Physiol       Date:  1975-10       Impact factor: 5.182

View more
  9 in total

1.  Increase in Na+/K+ pump numbers in vivo in healthy volunteers taking oral lithium carbonate and further upregulation in response to lithium in vitro.

Authors:  I J Antia; C E Dorkins; A J Wood; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  Leucocyte sodium pumps in patients with essential hypertension.

Authors:  V Oh; E Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

3.  Discrepancy between the short and long term effects of ouabain on the sodium pumps of human cells grown in culture.

Authors:  N M Griffiths; P H Ogden; R Cormack; J F Lamb
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

4.  Reversible inhibition of leucocyte sodium pumps by a circulating serum factor in essential hypertension.

Authors:  V M Oh; E A Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-14

5.  Effects of serum, lithium, ethacrynic acid, and low external concentration of potassium on specific [3H]-ouabain binding to human lymphocytes.

Authors:  V M Oh; E A Taylor
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

6.  The effects of serum, lithium, ethacrynic acid, and a low external concentration of potassium on specific [3H]-ouabain binding to human lymphocytes after incubation for 3 days.

Authors:  W G Rapeport; J K Aronson; D G Grahame-Smith; C Harper
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

7.  Linearity of metoclopramide kinetics at doses of 5-20 mg.

Authors:  M R Wright; J E Axelson; D W Rurak; B McErlane; G H McMorland; R C Ongley; Y K Tam; J D Price
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

8.  3H-Ouabain binding to human mononuclear leucocytes.

Authors:  K Ludwig; L Brown; E Erdmann
Journal:  Klin Wochenschr       Date:  1985-10-15

9.  Ouabain inhibition of the sodium-potassium pump: estimation of ED50 in different types of human leucocytes in vitro.

Authors:  B Møller; A Vaag; T Johansen
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.